These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6283226)

  • 1. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease.
    Cannon GB; Barsky SH; Alford TC; Jerome LF; Tinley V; McCoy JL; Dean JH
    J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB; Dyer CA; Mortensen RF
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
    Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
    Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of the simultaneous cell-mediated immune reactivity to RIII murine mammary tumor virus glycoprotein 55 and human breast cancer tissues.
    Zachrau RE; Black MM; Dion AS; Shore B; Williams CJ; Leis HP
    Cancer Res; 1978 Oct; 38(10):3414-20. PubMed ID: 80264
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
    Black MM; Zachrau RE; Shore B; Dion AS; Leis HP
    Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral leukocyte migration inhibition reactivity to breast cancer antigens in patients with breast cancer and in normal controls.
    Brandes LJ; Goldenberg GJ
    Cancer Res; 1976 Oct; 36(10):3707-10. PubMed ID: 953996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic and family studies of immunological responses to antigens of the murine mammary tumor virus in sera of patients with breast cancer.
    Day NK; Witkin SS; Sarkar NH; Kinne D; Jussawalla DJ; Levin A; Hsia CC; Good RA
    Trans Assoc Am Physicians; 1980; 93():123-9. PubMed ID: 6264656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
    Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
    Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphoproliferative responses to mouse mammary tumor virus in lymphocyte subsets of breast cancer patients.
    Lopez DM; Parks WP; Silverman MA; Distasio JA
    J Natl Cancer Inst; 1981 Aug; 67(2):353-8. PubMed ID: 6267344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
    Black MM; Zachrau RE
    J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The leukocyte migration inhibition response to certain breast cancer-related antigens (MCF-7 and MuMTV): their potential as discriminants.
    Wanebo HJ; Fukuda M; Tsuei L; Sarkar N; Ashikari H
    Surgery; 1979 Aug; 86(2):275-83. PubMed ID: 462374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular antitumor immune response in women with risk factors for breast cancer.
    Sanner T; Brennhovd I; Christensen I; Jørgensen O; Kvaløy S
    Cancer Res; 1979 Feb; 39(2 Pt 2):654-7. PubMed ID: 761231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of serum from breast cancer patients to murine mammary tumor virus: fact or artifact?
    Dion AS; Girardi AJ; Williams CC; Pomenti AA; Redfield ES
    J Natl Cancer Inst; 1987 Aug; 79(2):207-11. PubMed ID: 3037149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of mouse hyperplastic mammary outgrowth lines from BALB/cfC3H hyperplastic alveolar nodules.
    Ashley RL; Cardiff RD; Mitchell DJ; Faulkin LJ; Lund JK
    Cancer Res; 1980 Nov; 40(11):4232-42. PubMed ID: 6258774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
    Lee C; Chen S; Lin T
    Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.